Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
Albuterol 1.25mg / Ipratropium 0.5mg/ Budesonide 0.25mg Recalled by Integrated Health Concepts Inc. dba Conversio Health Due to Lack of Processing Controls
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Integrated Health Concepts Inc. dba Conversio Health directly.
Affected Products
Albuterol 1.25mg / Ipratropium 0.5mg/ Budesonide 0.25mg, 3ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401.
Quantity: N/A
Why Was This Recalled?
Lack of Processing Controls
Where Was This Sold?
This product was distributed nationwide across all 50 states.
About Integrated Health Concepts Inc. dba Conversio Health
Integrated Health Concepts Inc. dba Conversio Health has 10 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report